Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed)

US National Institutes of Health (NIH) grant open #PAR-25-113

Response due Sep 07, 2027 · 00:00 UTC

Summary

This NIH funding opportunity (PAR-25-113) solicits R21 exploratory/developmental research grants focused on advancing and innovating measurement methods related to language development and its predictors. Clinical trials are explicitly excluded. The mechanism is designed to support novel, high-impact research in early-stage or untested approaches to measuring language development trajectories and associated predictive factors.

What they want

Technical requirements

Clinical trials are not allowed under this funding opportunity
Must conform to NIH R21 exploratory/developmental research grant mechanism requirements

How they evaluate

Submission: Grants.gov federal grants portal (PAR-25-113)

Risks & flags

No dollar value or budget cap stated in the available text — award size is indeterminate from this record alone
Extremely long open window (Nov 2024 – Sep 2027) is typical for NIH standing program announcements but may reflect limited specificity in scope

Market context

inferred from NAICS

R&D in Physical, Engineering, Life Sciences (except Nanotech & Biotech)

NAICS 541715

US market size: $95B
Typical award: $100K – $50M+

Typical buyers

DoDNSFNIHNASADOE

Commonly required

DCAA-compliant accountingITARCMMC L2

Advancement and Innovation in Measurement …

Due Sep 07

Onboard ↗